Evidence map›Paper›PMID 29787272›Full record

ArticleThe journal of physical chemistry. B2018

Effects of pH and Oxidants on the First Steps of Polydopamine Formation: A Thermodynamic Approach.

Mikko Salomäki, Lauri Marttila, Henri Kivelä, Tuomo Ouvinen, Jukka Lukkari

Open access · hybridAbstract read
In one paragraph

Article in The journal of physical chemistry. B, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 211 citations in OpenAlex.

  1. Article
  2. Solvent-free grinding synthesis of Hemin@PAnalytical and bioanalytical chemistry · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Galvanically Deposited FeChemistry, an Asian journal · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mikko SalomäkiDepartment of Chemistry , University of Turku , FI-20014 Turku , Finland.ORCID 0000-0001-6190-2073
Lauri MarttilaDepartment of Chemistry , University of Turku , FI-20014 Turku , Finland.ORCID 0000-0002-8221-0954
Henri KiveläDepartment of Chemistry , University of Turku , FI-20014 Turku , Finland.ORCID 0000-0003-1414-8893
Tuomo OuvinenDepartment of Chemistry , University of Turku , FI-20014 Turku , Finland.
Jukka LukkariDepartment of Chemistry , University of Turku , FI-20014 Turku , Finland.ORCID 0000-0002-9409-7995
University of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a general thermodynamic top-down analysis of the effects of oxidants and pH on dopamine oxidation and cyclization, supplemented with UV-vis and electrochemical studies. The model is applicable to other catecholamines and various experimental conditions. The results show that the decisive physicochemical parameters in autoxidation are the p K values of the semiquinone and the amino group in the oxidized quinone. Addition of Ce(IV) or Fe(III) enhances dopamine oxidation in acidic media in aerobic and anaerobic conditions by the direct oxidation of dopamine and, in the presence of oxygen, also by the autoxidation of the formed semiquinone. At pH 4.5, the enhancement of the one-electron oxidation of dopamine explains the overall reaction enhancement, but at a lower pH, cyclization becomes rate-determining. Oxidation by Cu(II) at reasonable rates requires the presence of oxygen or chloride ions.

Identifiers

PMID29787272
PMCPMC6150685
OpenAlexW2804973142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.